Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: A Gynecologic Oncology Group Study. - Muggia,F.M.; Braly,P.S.; Brady,M.F.; Sutton,G.; Niemann,T.H.; Lentz,S.L.; Alvarez,R.D.; Kucera,P.R.; Small,J.M. (J Clin Oncol, 2000)